James George Chopas - 20 Oct 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
VP/Chief Accounting Officer
Signature
/s/ David Watson, attorney-in-fact for James Chopas
Issuer symbol
APLS
Transactions as of
20 Oct 2022
Net transactions value
-$7,540
Form type
4
Filing time
24 Oct 2022, 17:09:05 UTC
Previous filing
31 Aug 2022
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability $7,540 -130 -0.7% $58.00 18,451 20 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.